182 related articles for article (PubMed ID: 23318366)
21. The accelerated blood clearance (ABC) phenomenon: clinical challenge and approaches to manage.
Abu Lila AS; Kiwada H; Ishida T
J Control Release; 2013 Nov; 172(1):38-47. PubMed ID: 23933235
[TBL] [Abstract][Full Text] [Related]
22. Transport of PEGylated liposomes from the splenic marginal zone to the follicle in the induction phase of the accelerated blood clearance phenomenon.
Shimizu T; Ishida T; Kiwada H
Immunobiology; 2013 May; 218(5):725-32. PubMed ID: 22995937
[TBL] [Abstract][Full Text] [Related]
23. Relationship between the concentration of anti-polyethylene glycol (PEG) immunoglobulin M (IgM) and the intensity of the accelerated blood clearance (ABC) phenomenon against PEGylated liposomes in mice.
Hashimoto Y; Shimizu T; Abu Lila AS; Ishida T; Kiwada H
Biol Pharm Bull; 2015; 38(3):417-24. PubMed ID: 25757923
[TBL] [Abstract][Full Text] [Related]
24. The effect of PEG coating on in vitro cytotoxicity and in vivo disposition of topotecan loaded liposomes in rats.
Dadashzadeh S; Vali AM; Rezaie M
Int J Pharm; 2008 Apr; 353(1-2):251-9. PubMed ID: 18191511
[TBL] [Abstract][Full Text] [Related]
25. A hydroxyl PEG version of PEGylated liposomes and its impact on anti-PEG IgM induction and on the accelerated clearance of PEGylated liposomes.
Shimizu T; Abu Lila AS; Fujita R; Awata M; Kawanishi M; Hashimoto Y; Okuhira K; Ishima Y; Ishida T
Eur J Pharm Biopharm; 2018 Jun; 127():142-149. PubMed ID: 29462689
[TBL] [Abstract][Full Text] [Related]
26. Anti-PEG IgM Is a Major Contributor to the Accelerated Blood Clearance of Polyethylene Glycol-Conjugated Protein.
Mima Y; Hashimoto Y; Shimizu T; Kiwada H; Ishida T
Mol Pharm; 2015 Jul; 12(7):2429-35. PubMed ID: 26070445
[TBL] [Abstract][Full Text] [Related]
27. Repeated injection of PEGylated solid lipid nanoparticles induces accelerated blood clearance in mice and beagles.
Zhao Y; Wang L; Yan M; Ma Y; Zang G; She Z; Deng Y
Int J Nanomedicine; 2012; 7():2891-900. PubMed ID: 22745552
[TBL] [Abstract][Full Text] [Related]
28. [Elucidation of accelerated blood clearance phenomenon caused by repeat injection of PEGylated nanocarriers].
Koide H; Asai T; Hatanaka K; Shimizu K; Yokoyama M; Ishida T; Kiwada H; Oku N
Yakugaku Zasshi; 2009 Dec; 129(12):1445-51. PubMed ID: 19952519
[TBL] [Abstract][Full Text] [Related]
29. Particle size-dependent triggering of accelerated blood clearance phenomenon.
Koide H; Asai T; Hatanaka K; Urakami T; Ishii T; Kenjo E; Nishihara M; Yokoyama M; Ishida T; Kiwada H; Oku N
Int J Pharm; 2008 Oct; 362(1-2):197-200. PubMed ID: 18586076
[TBL] [Abstract][Full Text] [Related]
30. Induction of Cytochrome P450 Involved in the Accelerated Blood Clearance Phenomenon Induced by PEGylated Liposomes In Vivo.
Wang F; Wu Y; Zhang J; Wang H; Xie X; Ye X; Peng D; Chen W
Drug Metab Dispos; 2019 Apr; 47(4):364-376. PubMed ID: 30674617
[TBL] [Abstract][Full Text] [Related]
31. Effect of Repeated Injections of Adenosine Diphosphate-Encapsulated Liposomes Coated with a Fibrinogen γ-Chain Dodecapeptide Developed as a Synthetic Platelet Substitute on Accelerated Blood Clearance in a Healthy and an Anticancer Drug-Induced Thrombocytopenia Rat Model.
Taguchi K; Hashimoto M; Ogaki S; Watanabe H; Takeoka S; Ikeda Y; Handa M; Otagiri M; Maruyama T
J Pharm Sci; 2015 Sep; 104(9):3084-91. PubMed ID: 25755009
[TBL] [Abstract][Full Text] [Related]
32. Hydrophobic blocks of PEG-conjugates play a significant role in the accelerated blood clearance (ABC) phenomenon.
Shiraishi K; Hamano M; Ma H; Kawano K; Maitani Y; Aoshi T; Ishii KJ; Yokoyama M
J Control Release; 2013 Feb; 165(3):183-90. PubMed ID: 23220106
[TBL] [Abstract][Full Text] [Related]
33. [Accelerated blood clearance (ABC) phenomenon induced by administration of PEGylated liposome].
Ishida T; Kiwada H
Yakugaku Zasshi; 2008 Feb; 128(2):233-43. PubMed ID: 18239370
[TBL] [Abstract][Full Text] [Related]
34. Accelerated Blood Clearance of Nanoemulsions Modified with PEG-Cholesterol and PEG-Phospholipid Derivatives in Rats: The Effect of PEG-Lipid Linkages and PEG Molecular Weights.
Liu M; Chu Y; Liu H; Su Y; Zhang Q; Jiao J; Liu M; Ding J; Liu M; Hu Y; Dai Y; Zhang R; Liu X; Deng Y; Song Y
Mol Pharm; 2020 Apr; 17(4):1059-1070. PubMed ID: 31860321
[TBL] [Abstract][Full Text] [Related]
35. Influence of phospholipid types and animal models on the accelerated blood clearance phenomenon of PEGylated liposomes upon repeated injection.
Xu H; Ye F; Hu M; Yin P; Zhang W; Li Y; Yu X; Deng Y
Drug Deliv; 2015; 22(5):598-607. PubMed ID: 24524364
[TBL] [Abstract][Full Text] [Related]
36. Accelerated blood clearance phenomenon upon cross-administration of PEGylated nanocarriers in beagle dogs.
Wang C; Cheng X; Su Y; Pei Y; Song Y; Jiao J; Huang Z; Ma Y; Dong Y; Yao Y; Fan J; Ta H; Liu X; Xu H; Deng Y
Int J Nanomedicine; 2015; 10():3533-45. PubMed ID: 25999716
[TBL] [Abstract][Full Text] [Related]
37. Abrogation of the accelerated blood clearance phenomenon by SOXL regimen: promise for clinical application.
Nagao A; Abu Lila AS; Ishida T; Kiwada H
Int J Pharm; 2013 Jan; 441(1-2):395-401. PubMed ID: 23174409
[TBL] [Abstract][Full Text] [Related]
38. Differences in colloidal structure of PEGylated nanomaterials dictate the likelihood of accelerated blood clearance.
Kaminskas LM; McLeod VM; Porter CJ; Boyd BJ
J Pharm Sci; 2011 Nov; 100(11):5069-77. PubMed ID: 21721002
[TBL] [Abstract][Full Text] [Related]
39. Application of polyglycerol coating to plasmid DNA lipoplex for the evasion of the accelerated blood clearance phenomenon in nucleic acid delivery.
Abu Lila AS; Uehara Y; Ishida T; Kiwada H
J Pharm Sci; 2014 Feb; 103(2):557-66. PubMed ID: 24347396
[TBL] [Abstract][Full Text] [Related]
40. Size-dependent induction of accelerated blood clearance phenomenon by repeated injections of polymeric micelles.
Koide H; Asai T; Kato H; Ando H; Shiraishi K; Yokoyama M; Oku N
Int J Pharm; 2012 Aug; 432(1-2):75-9. PubMed ID: 22562054
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]